Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels

Benzer Materyaller

• Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management
  Yazar:: Chicca, Ilaria J., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
  Yazar:: de Tute, Ruth M., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
  Yazar:: Heaney, Jennifer L. J., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial
  Yazar:: Rana, Ritika, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study
  Yazar:: Ilaria J Chicca, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-12-01)